Literature DB >> 9331563

Cytogenetic analysis of three breast carcinoma cell lines using reverse chromosome painting.

J S Morris1, N P Carter, M A Ferguson-Smith, P A Edwards.   

Abstract

Chromosome painting was used to determine the copy number and identity of virtually all the chromosomes in three breast cancer cell lines, T-47D, MDA-MB-361, and ZR-75-1. The karyotypes of all three cell lines were very complex, and were consistent with the monosomic pattern of evolution suggested by Dutrillaux, in which nonreciprocal translocations cause an initial reduction in chromosome number, followed by duplication of the entire genome and further chromosome loss. Twenty distinct abnormal chromosomes were identified in T-47D, seven of which were present as two copies. MDA-MB-361 had 27 abnormal chromosomes each as a single copy. Thirteen abnormal chromosomes in ZR-75-1 occurred singly, two were paired, and one was present as three copies. Most of the aberrant chromosomes were nonreciprocal translocations, although deletions, duplications, isochromosomes, and amplifications (HSR of 1q) were also found. Chromosome arms present in abnormal chromosomes in all three lines were 1q, 6p, 7p, 8p, 8q, 10q, 11p, 11q, 12p, 13q, 14q, 15q, 16p, 16q, 17q, and 20q. The only chromosome arms present in four or more copies in all three lines were 8q and proximal 12p, while 1p, 17p, and bands 11q12--13 were the only chromosome regions consistently reduced to two copies. The most striking feature common to all three lines was a translocation breakpoint on the short arm of chromosome 8 at 8p12.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331563     DOI: 10.1002/(sici)1098-2264(199710)20:2<120::aid-gcc3>3.0.co;2-5

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

Review 1.  Reverse painting highlights the origin of chromosome aberrations.

Authors:  Elisabeth Blennow
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

2.  Evaluation of 24-color multifluor-fluorescence in-situ hybridization (M-FISH) karyotyping by comparison with reverse chromosome painting of the human breast cancer cell line T-47D.

Authors:  Y J Lu; J S Morris; P A Edwards; J Shipley
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

3.  Genomic signatures of breast cancer metastasis.

Authors:  V Urquidi; S Goodison
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

4.  Single-molecule analysis of genome rearrangements in cancer.

Authors:  Jessica C M Pole; Frank McCaughan; Scott Newman; Karen D Howarth; Paul H Dear; Paul A W Edwards
Journal:  Nucleic Acids Res       Date:  2011-04-27       Impact factor: 16.971

5.  Molecular cytogenetic analysis of breast cancer cell lines.

Authors:  J M Davidson; K L Gorringe; S F Chin; B Orsetti; C Besret; C Courtay-Cahen; I Roberts; C Theillet; C Caldas; P A Edwards
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

6.  Gamma-heregulin has no biological significance in primary breast cancer.

Authors:  E A Sánchez-Valdivieso; J J Cruz; R Salazar; M del Mar Abad; A Gómez-Alonso; A Gómez; R González-Sarmiento
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

7.  The interrelationship between DRIM gene expression and cytogenetic and phenotypic characteristics in human breast tumor cell lines.

Authors:  Steve Goodison; Carrie Viars; Maren Grazzini; Virginia Urquidi
Journal:  BMC Genomics       Date:  2003-09-22       Impact factor: 3.969

8.  The Genomic Landscape of Centromeres in Cancers.

Authors:  Anjan K Saha; Mohamad Mourad; Mark H Kaplan; Ilana Chefetz; Sami N Malek; Ronald Buckanovich; David M Markovitz; Rafael Contreras-Galindo
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

9.  Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes.

Authors:  K D Howarth; K A Blood; B L Ng; J C Beavis; Y Chua; S L Cooke; S Raby; K Ichimura; V P Collins; N P Carter; P A W Edwards
Journal:  Oncogene       Date:  2007-12-17       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.